Portal de Periódicos da CAPES

A CONCISE GUIDE TO TOPICAL SUNSCREENS: STATE OF THE ART

1992; Wiley; Volume: 31; Issue: 8 Linguagem: Inglês

10.1111/j.1365-4362.1992.tb02713.x

1365-4632

Matthew J. Stiller, Ira C. Davis, Jerome L. Shupack,

Contact Dermatitis and Allergies

International Journal of DermatologyVolume 31, Issue 8 p. 540-543 A CONCISE GUIDE TO TOPICAL SUNSCREENS: STATE OF THE ART MATTHEW J. STILLER M.D., Corresponding Author MATTHEW J. STILLER M.D. From the Dermatopharmacology Section, Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York.Address for correspondence: Matthew Stiller, M.D., New York University Department of Dermatology, 550–560 First Avenue, New York, NY 10016.Search for more papers by this authorIRA C. DAVIS M.D., IRA C. DAVIS M.D. From the Dermatopharmacology Section, Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York.Search for more papers by this authorJEROME L. SHUPACK M.D., JEROME L. SHUPACK M.D. From the Dermatopharmacology Section, Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York.Search for more papers by this author MATTHEW J. STILLER M.D., Corresponding Author MATTHEW J. STILLER M.D. From the Dermatopharmacology Section, Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York.Address for correspondence: Matthew Stiller, M.D., New York University Department of Dermatology, 550–560 First Avenue, New York, NY 10016.Search for more papers by this authorIRA C. DAVIS M.D., IRA C. DAVIS M.D. From the Dermatopharmacology Section, Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York.Search for more papers by this authorJEROME L. SHUPACK M.D., JEROME L. SHUPACK M.D. From the Dermatopharmacology Section, Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York.Search for more papers by this author First published: August 1992 https://doi.org/10.1111/j.1365-4362.1992.tb02713.xCitations: 4 Supported in part by a grant from the National Institute of Health (Skin Disease Research Center Grant AR 39749) AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Council on Scientific Affairs, American Medical Association, Chicago, Illinois, Harmful effects of ultraviolet radiation. JAMA 1989; 262: 380–384. 2 Pathak MA. Sunscreens Topical and systemic approaches for the prevention of acute and chronic sun-induced skin reactions. Dermatol Clin 1986; 4: 321–333. 3 Matliews-Roth MM. Protective effect of (3-carotene against lethal photosensitization by haematoporphyrin. Nature 1964; 203: 1092. 4 Mathews-Roth MM, Pathak MA, Fitzpatrick TB, et al. Beta-carotene as a photoprotective agent in erythropoietic protoporphyria. New Engl J Med 1970; 282: 1231–1234. 5 Mathews-Roth MM, Pathak MA, Fitzpatrick TB, et al. B-Carotene as an oral photoprotective agent in erythropoietic protoporphyria. JAMA 1974; 228: 1004–1008. 6 Greenberg ER, Baron JA, Stukel TA, et al. A clinical trial of beta-carotene to prevent basal-cell and squamous-cell cancers of the skin. New Engl J Med 1990; 323: 789–795. 7 Mathews-Roth MM, Pathak MA, Parrish J, et al. A clinical trial of the effects of oral beta-carotene on the responses of human skin to solar radiation. J Invest Dermatol 1972; 59: 349–353. 8 Fitzpatrick TB, Pathak MA. Historical aspects of methoxsalen and other furocoumarins. J Invest Dermatol 1959; 32: 229–231. 9 Rodighiero G, Dall'Acqua F. Biochemical and medical aspects of psoralens. Photochem Photobiol 1976; 24: 647–653. 10 de Wolff FA, Thomas TV. Clinical pharmacokinetics of methoxsalen and other psoralens. Clin Pharmacokinet 1986; 11: 62–75. 11 Mackenzie AH. Pharmacologic actions of 4-amino-quinolone compounds. Am J Med 1983; 75(1A): 5–10. 12 Isaacson D, Elgart M, Turner ML. Anti-malarials in dermatology. Int J Dermatol 1982; 21: 379–395. 13 McChesney EW. Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate. Am J Med 1983; 75(1A): 11–17. 14 Peyron JL, Meynadier J. The pharmacological basis for the treatment of photodermatoses. Biocliimie 1986; 68: 899–904. 15 Scholnick PL, Epstein J, Marver HS. The molecular basis of the action of chloroquine in porphyria cutanea tarda. J Invest Dermatol 1973; 61: 226–232. 16 Mathews-Roth MM. Systemic photoprotection. Dermatol Clin 1986; 4: 335–339. 17 Greaves MW. Pharmacology and significance of nonsteroidal anti-inflammatory drugs in the treatment of skin diseases. J Am Acad Dermatol 1987; 16: 751–764. 18 Liechtenstein J, Flowers F, Sheretz EF. Nonsteroidal anti-inflammatory drugs: their use in dermatology. Int J Dermatol 1987; 26: 80–87. 19 Moseley H, MacFadyen EE, Ferguson MM, et al. Reduction of UV-induced erythema in normal subjects by applying methimazole. Photodermatol 1989; 6: 32–36. 20 Murray J, Darr D, Reich J, et al. Topical vitamin C treatment reduces ultraviolet B radiation-induced erythema in human skin. J Invest Dermatol 1991; 96: 587. 21 Lowe NJ. Photoprotection. Semin Dermatol 1990; 9: 78–83. 22 Edwards EK Jr, Edwards EK. Sunburn and sunscreens: an update and review. Milit Med 1990; 155: 381–383. 23 Lowe NJ. Sunscreens and the prevention of skin aging. J Dermatol Surg Oncol 1990; 160: 936–938. 24 Kaidbey KH. The photoprotective potential of the new super potent sunscreens.) Am Acad Dermatol 1990; 22: 449–452. 25 DeRickje S, Heenen M. Decrease of ultraviolet-induced DNA injury in human skin by p-aminobenzoic acid esters. Dermatologica 1989; 179: 196–199. 26 Freeman SE, Ley RD, Ley KD. Sunscreen protection against UV-induced pyrimidine dimers in DNA of human skin in situ. Photodermatol 1988; 5: 243–247. 27 Kligman LH. Prevention and repair of photoaging: sunscreens and retinoids. Cutis 1989; 43: 458–465. 28 Lowe NJ, Weingarten D, Wortzman M. Sunscreens and phototesting. Clin Dermatol 1988; 6: 40–49. 29 DeLeo VA. Prevention of skin cancer. J Dermatol Surg Oncol 1988; 14: 902–906. 30 Kligman LH. Preventing, delaying, and repairing photo aged skin. Cutis 1988; 41: 419–420. 31 Straus JS. Sunscreens. Iowa Med 1988; 78: 87–89. 32 Kligman LH. Photoaging manifestations, prevention and treatment. Clin Geriatr Med 1989; 5: 235–251. 33 Furukawa RD, Brown WR, Shivji GM, et al. Assessment by mouse model of the ultraviolet A protective effect of topical sunscreens. J Am Acad Dermatol 1989; 20: 1031–1037. 34 Kawada A, Hiruma M, Nakada R, et al. An evaluation of broad spectrum sunscreens against topical PUVA-induced erythema. Acta Derm Venereol 1989; 69: 335–337. 35 Ramsay CA. Ultraviolet A protective sunscreens. Clin Dermatol 1989; 7: 163–166. 36 Manser A. Selecting a sunscreen agent. Aust Nurses J 1990; 19: 27. 37 Rumsfield J. Sunscreens: what you and your patients should know. Dermatol Nurs 1990; 2: 134–137. 38 Sayre RM, Agin PP. A method for the determination of UVA protection for normal skin. J Am Acad Dermatol 1990; 23: 429–440. 39 Roelandts R, Sohrabvand N, Garmyn M. Evaluating the UVA protection of sunscreens. J Am Acad Dermatol 1989; 21: 56–62. 40 Stanfield JW, Feldt PA, Csortan ES, et al. Ultraviolet A sunscreen evaluations in normal subjects. J Am Acad Dermatol 1989; 20: 744–748. 41 Summers AB, Summers RS. UVA filters in sunscreen preparations. Lancet 1989; i: 1387. 42 Pathak MA. Sunscreens and their use in the preventive treatment of sunlight-induced skin damage. J Dermatol Surg Oncol 1987; 13: 739–750. 43 Menter JM. Recent developments in UVA photoprotection. Int J Dermatol 1990; 29: 389–394. 44 Lowe NJ, Dromgoole SH, Sefton J, et al. Indoor and outdoor efficacy testing of a broad-spectrum sunscreen against ultraviolet A radiation in psoralen-sensitized subjects. J Am Acad Dermatol 1987; 17: 224–230. 45 Agin PP, Sayre RM. Sun protection factors of proprietary sunscreens can be determined with precision. Photodermatol 1986; 3: 358–362. 46 Garmyn MA, Murphy GM, Gibbs NK, et al. Are the protection factors assigned to proprietary sunscreen products misleading Photodermatol 1986; 3: 104–106. 47 Urbach F. Testing the efficacy of sunscreens: effect of choice of source, spectral power distribution of ultraviolet radiation, and choice of endpoint. Photodermatol 1989; 6: 177–181. 48 Imhof RE, Whitters CJ, Birch DJ. Optothermal in two monitoring of sunscreens on skin. Phys Med Biol 1990; 22: 340–342. 49 Cole CA, Forbes DP, Ludwigsen K. Sunscreen testing using the mouse ear model. Photodermatol 1989; 6: 131–136. 50 Cole CA, Sambuco C, Forbes PD, et al. Response to ultraviolet irradiation: ear swelling in hairless mice. Photodermatol 1984; 1: 114–118. 51 Hurwitz S. The sun and sunscreen protection: recommendations for children. J Dermatol Surg Oncol 1988; 14: 657–660. 52 Hersey P, MacDonald M, Henderson C, et al. Suppression of natural killer cell activity in humans by radiation from solarium lamps depleted of UVB. J Invest Dermatol 1988; 90: 305–310. 53 Mommaas AM, Van Praag MCG, Bavinck JNB, et al. Analysis of the protective effect of topical sunscreens on the UVB-radiation-induced suppression of the mixed lymphocyte reaction. J Invest Dermatol 1990; 95: 313–316. 54 Dromgoole SH, Maibach HM. Sunscreening agent intolerance: contact and photocontact sensitization and contact urticaria. J Am Acad Dermatol 1990; 22: 1068–1078. 55 Thune P. Contact and photocontact allergy to sunscreens. Photodermatol 1984; 1: 5–9. 56 Knobler E, Almeida L, Ruzkowski AM, et al. Photo-allergy to benzophenone. Arch Dermatol 1989; 125: 301–304. Citing Literature Volume31, Issue8August 1992Pages 540-543 ReferencesRelatedInformation